Breakthrough Technology. Breakthrough Outcomes.

The evidence is here.

A clinical study conducted at CHU Limoges, France demonstrated the clinical value of implementing a hospital-wide goal-directed therapy (GDT) protocol for blood and fluid management using Masimo noninvasive, continuous hemoglobin (SpHb®) and pleth variability index (PVi®) monitoring.

Leave a comment